🇺🇸 FDA
Company

Lakefront

Lakefront Biotherapeutics NV

LKFT pharma USA

Quick answer

Lakefront is a pharma company (LKFT) headquartered in 2800 MECHELEN, USA with 24 tracked pipeline programs.

Pipeline (24)

project

Filgotinib

Psoriatic Arthritis

Phase 3 · small_molecule · terminated

4 trials project

Filgotinib

Ulcerative Colitis

Phase 3 · small_molecule · completed

2 trials project

Filgotinib

Crohn's Disease

Phase 3 · small_molecule · terminated

2 trials project

Filgotinib

Ankylosing Spondylitis

Phase 3 · small_molecule · terminated

3 trials project

GLPG CAR T-cell therapy

Hematological Malignancies

Phase 3 · gene_therapy · active

1 trials project

GLPG1690

Idiopathic Pulmonary Fibrosis

Phase 3 · small_molecule · terminated

2 trials project

Filgotinib

Inflammatory Bowel Disease

Phase 2 · small_molecule · terminated

1 trials project

Filgotinib

Fistulizing Crohn's Disease

Phase 2 · small_molecule · completed

1 trials project

Filgotinib

Noninfectious Uveitis

Phase 2 · small_molecule · terminated

1 trials project

Filgotinib

Small Bowel Crohn's Disease

Phase 2 · small_molecule · completed

1 trials project

GLPG0259 oral capsule

Rheumatoid Arthritis

Phase 2 · small_molecule · completed

1 trials project

GLPG0634

Crohn's Disease

Phase 2 · small_molecule · completed

1 trials project

GLPG0634

Rheumatoid Arthritis

Phase 2 · small_molecule · completed

4 trials project

GLPG0974

Ulcerative Colitis

Phase 2 · small_molecule · completed

1 trials project

GLPG1205

Idiopathic Pulmonary Fibrosis

Phase 2 · small_molecule · completed

1 trials project

GLPG1205

Ulcerative Colitis

Phase 2 · small_molecule · completed

1 trials project

GLPG1690

Systemic Sclerosis

Phase 2 · small_molecule · terminated

2 trials project

GLPG1690 600 mg QD

Idiopathic Pulmonary Fibrosis

Phase 2 · small_molecule · completed

1 trials project

GLPG1837 dose 1

Cystic Fibrosis

Phase 2 · small_molecule · completed

2 trials project

GLPG1972

Osteoarthritis

Phase 2 · small_molecule · completed

1 trials project

GLPG2222 150 mg q.d.

Cystic Fibrosis

Phase 2 · small_molecule · completed

1 trials project

GLPG2222 50 mg

Cystic Fibrosis

Phase 2 · small_molecule · completed

1 trials project

GLPG2737

Autosomal Dominant Polycystic Kidney Disease

Phase 2 · small_molecule · terminated

1 trials project

GLPG2737

Cystic Fibrosis

Phase 2 · small_molecule · completed

1 trials